A new drug made from cannabis has been licensed in the UK. Sativex, a tincture of extracts from the plant, is sprayed under the tongue up to 12 times a day, as a treatment for the stiffness and spasticity associated with multiple sclerosis. The Home Office has rated it as having zero abuse potential. Britain is the first country to give the drug full regulatory approval, although Canada gave Sativex a limited license to treat neuropathic pain in 2005. It is made from plants grown at a secret location in southern England by GW Pharmaceuticals, whose shares have risen 60% in the last six months in anticipation of the new product.
Recent comments
17 weeks 5 days ago
21 weeks 6 days ago
23 weeks 3 days ago
23 weeks 4 days ago
35 weeks 6 days ago
41 weeks 4 days ago
1 year 3 days ago
1 year 1 week ago
1 year 3 weeks ago
1 year 3 weeks ago